Bill Szablewski

Public Communications Contact presso VIATRIS INC.

Health Technology

Profilo

Bill Szablewski is currently the Head-Capital Markets at Viatris, Inc. He previously worked as the Head-Capital Markets at Mylan NV and as the Assistant Treasurer-Capital Markets at Bristol Myers Squibb Co.

Posizioni attive di Bill Szablewski

Società	Posizione	Inizio
VIATRIS INC.	Public Communications Contact	16/11/2020

Tutte le posizioni attive di Bill Szablewski

Precedenti posizioni note di Bill Szablewski

Società	Posizione	Fine
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	-
Mylan NV Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Bill Szablewski

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Bill Szablewski

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
VIATRIS INC.	Health Technology

Aziende private	1
Mylan NV Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.	Health Technology